Healthcare/Biotech
|
Updated on 07 Nov 2025, 07:05 am
Reviewed By
Aditi Singh | Whalesbook News Team
▶
Divi's Laboratories announced its financial results for the September quarter, showcasing significant growth across key metrics. The company's revenue reached ₹2,715 crore, marking a 16% increase compared to the ₹2,338 crore reported in the same quarter last year. This performance surpassed the CNBC-TV18 poll estimate of ₹2,608 crore. Net profit saw an even more substantial rise of 35% year-on-year, climbing to ₹689 crore from ₹510 crore, also exceeding the Street's estimate of ₹612 crore. The company also benefited from a foreign exchange gain of ₹63 crore, up from ₹29 crore a year prior. Operating profit, or EBITDA, grew by 24% to ₹888 crore from ₹716 crore, beating the poll estimate of ₹823 crore. Furthermore, the EBITDA margin expanded by 210 basis points to 32.7% from 30.6% a year ago, outperforming the poll estimate of 31.5%.
Impact This strong earnings report is likely to be viewed positively by investors, potentially leading to increased confidence in Divi's Laboratories' stock. The consistent year-on-year growth, coupled with margin expansion and beating estimates on multiple fronts, suggests efficient operations and robust demand for its products. The market may react favorably, though the stock's current trading price (down 3.42% at ₹6,656.70 from its day's high) indicates potential profit-taking or mixed market sentiment. Despite the intraday dip, the stock's 10% rise in the last month highlights positive investor interest. Impact rating: 8/10
Difficult Terms Explained: EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a company's operating performance. EBITDA Margin: It is calculated by dividing EBITDA by total revenue. It indicates how profitable a company is as a percentage of its revenue, reflecting operational efficiency. Basis Points: A basis point is one-hundredth of one percent. 100 basis points equal 1%. So, a 210 basis point expansion means a 2.10% increase in the EBITDA margin.